iohexol has been researched along with Neointima in 3 studies
Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.
Neointima: The new and thickened layer of scar tissue that forms on a PROSTHESIS, or as a result of vessel injury especially following ANGIOPLASTY or stent placement.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Paclitaxel delivery to porcine ilio-femorals using PCB followed by BMS implantation effectively decreased neointimal proliferation." | 3.77 | Paclitaxel-iopromide coated balloon followed by "bail-out" bare metal stent in porcine iliofemoral arteries: first report on biological effects in peripheral circulation. ( Aboodi, MS; Conditt, GB; Granada, JF; Gray, WA; Kaluza, GL; McGregor, JC; Milewski, K; Stenoien, M; Tellez, A; Thim, T; Virmani, R; Yi, GH, 2011) |
| "In histology, percentage area of stenosis (BMS+PCB=29." | 1.39 | Stent healing response following delivery of paclitaxel via durable polymeric matrix versus iopromide-based balloon coating in the familial hypercholesterolaemic swine model of coronary injury. ( Afari, M; Buszman, PP; Cheng, Y; Conditt, GB; Granada, JF; Kaluza, GL; McGregor, JC; Milewski, K; Stenoien, M; Tellez, A, 2013) |
| "Paclitaxel tissue uptake was assessed in 20 iliofemoral arteries of a domestic swine." | 1.39 | Tissue uptake, distribution, and healing response after delivery of paclitaxel via second-generation iopromide-based balloon coating: a comparison with the first-generation technology in the iliofemoral porcine model. ( Afari, ME; Buszman, PP; Conditt, GB; Granada, JF; Kaluza, GL; McGregor, JC; Peppas, A; Rousselle, SD; Stenoien, M; Tellez, A, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buszman, PP | 2 |
| Tellez, A | 3 |
| Afari, M | 1 |
| Cheng, Y | 1 |
| Conditt, GB | 3 |
| McGregor, JC | 3 |
| Milewski, K | 2 |
| Stenoien, M | 3 |
| Kaluza, GL | 3 |
| Granada, JF | 3 |
| Afari, ME | 1 |
| Peppas, A | 1 |
| Rousselle, SD | 1 |
| Aboodi, MS | 1 |
| Yi, GH | 1 |
| Thim, T | 1 |
| Gray, WA | 1 |
| Virmani, R | 1 |
3 other studies available for iohexol and Neointima
| Article | Year |
|---|---|
Stent healing response following delivery of paclitaxel via durable polymeric matrix versus iopromide-based balloon coating in the familial hypercholesterolaemic swine model of coronary injury.
Topics: Angioplasty, Balloon, Coronary; Animals; Cardiovascular Agents; Constriction, Pathologic; Coronary A | 2013 |
Tissue uptake, distribution, and healing response after delivery of paclitaxel via second-generation iopromide-based balloon coating: a comparison with the first-generation technology in the iliofemoral porcine model.
Topics: Angioplasty, Balloon; Animals; Arterial Occlusive Diseases; Cardiovascular Agents; Cell Proliferatio | 2013 |
Paclitaxel-iopromide coated balloon followed by "bail-out" bare metal stent in porcine iliofemoral arteries: first report on biological effects in peripheral circulation.
Topics: Angioplasty, Balloon; Animals; Blood Circulation; Cell Proliferation; Dose-Response Relationship, Dr | 2011 |